4:20 pm : The major averages closed mixed Monday as investors turned their focus to earnings and paid particular attention to the growth prospects (or lack thereof) for all 10 economic sectors.
Wall Street forecasts for the SnP 500 now calling for aggregate Q2 operating earnings growth of 11-12%, up from single digits early in the quarter that threatened to snap a winning streak of 11 straight quarters of double-digit profit growth, was the main focus Monday. Alcoa (AA 33.41 -0.14), which was scheduled to kick off earnings season officially after the close, underpinned an
Skip the Butter. Cooking with canola or olive oil may reduce heart disease risk. Just remember that even these "good" fats are loaded with calories, so use them in moderation.
More
NATALEE'S UNCLE SAYS 'RE-ARREST DEEPAK!'
Natalee Holloway's uncle is demanding that suspect Deepak Kalpoe be re-arrested in the 10-month-old mystery of the pretty blonde honor student who disappeared in Aruba. Deepak, his brother Satish and Joran van der Sloot were with the Alabama teen, pictured center, when she was last seen leaving a bar on the island in the early hours of May 30. Her uncle Paul Reynolds told The National Enquirer that he believes Deepak, 21, should be the chief suspect instead of van der Sloot, 18. Reynolds also... •STAR JONES CHEATS DEATH AS SHE UNDERGOES PLASTIC SURGERY •A WILD NIGHT OUT FOR JESSE & HIS PARTY PAL LINDSAY
Star Magazine
KATIE HOLMES: FEARING FOR HER TOMKITTEN
Katie Holmes was already worried about the upcoming birth of her baby. According to the tenets of 43-year-old fiancé Tom Cruise's religion, Scientology, she'll have to be silent (not even a moan!) during the delivery, lest the trauma be imprinted in her baby's brain. Plus, a source says, "Only Tom and a few Scientology supporters will be in the room — not Katie's mother!" And Scientology advocates separating the baby from its mother for at least the first 24 hours after birth. Now... •IT'S OVER! KRISTIN CHEATS ON NICK WITH HER EX! •ANGELINA PILOTING HER PLANE AT 7 1/2 MONTHS: IS SHE CRAZY?
Group claims 3 GIs killed over rape-murders Neighbor and eyewitness Hussein Mohammed, 33, points to the charred and blood splattered floor and wall where he found the body of the young Iraqi girl who was allegedly raped then killed along with family members in their home, Thursday, July 6, 2006, in Mahmoudiya, south of Baghdad, Iraq. Former US Army Pfc. Steve D. Green was charged Monday in federal court in Charlotte, North Carolina, with rape and four counts of murder. At least four other U.S. soldiers still in Iraq are under investigation in the attack. (AP Photo/Ali al-Mahmouri)
3:30 pm PT Franklin Resources Announces Stock Repurchase Program (BEN) 83.44 +0.94 : Co announced that its Board of Directors authorized the co to purchase, from time to time, up to an aggregate of 10.0 mln shares of its common stock in either open market or private transactions.�The stock repurchase program is not subject to an expiration date. The new board authorization is in addition to the existing authorization, of which 22,139 shares remain available for repurchase at July 5, 2006. The co repurchased an aggregate of 9,799,000 shares during the quarter ended June 30, 2006. Shares repurchased under the program are retired. There were approximately 253.6 mln shares of the co's common stock issued and outstanding on June 30, 2006.
2:38 pm PT Molecular Devices Introduces Its Next-Generation No-Wash, Cell-Based Calcium Assay Kit For GPCR Screening (MDCC) 29.57 -0.31 : Co introduced its next-generation no-wash calcium flux assay -- the FLIPR Calcium 4 Assay Kit. Molecular Devices' cell based, no-wash calcium kits, first introduced in 1999, have become the standard for GPCR screening in laboratories worldwide. This new kit includes a masking technology licensed exclusively by Molecular Devices from Bayer AG.
2:38 pm PT Synergetics responds to Iridex press release on ruling in its pending patent case vs. Synergistics (SURG) 4.63 : SURG says that while the Markman ruling is more favorable to Iridex, such a ruling is only the first step in the overall infringement analysis, and the lawsuit is not set for trial�until spring 2007. SURG adds that counterclaims against Iridex relating to alleged false statements made by it in the marketplace about�SURG's�products, false advertising, and defamation remain in the case and have not yet been addressed by the court. Even if Iridex were successful in�its lawsuit, SURG says it�expects that any damages to which Iridex would be reasonably entitled would be a small fraction of sales.
Add Content
Change Layout
Change Colors
New mail
